Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data to DCGI by Next Week

India will resume export of surplus Covid-19 vaccines in the fourth quarter of 2021 under the Vaccine Maitri' programme and to meet its commitment to the COVAX global pool.

from Top India News- News18.com https://ift.tt/3nTEHD2